Schisandrin B enhances the glutathione redox cycling and protects against oxidant injury in different types of cultured cells

BioFactors

Volumn 37, Issue 6, 2011, Pages 439-446

  Lam, Philip Y ^a   Leong, Pou Kuan ^a   Chen, Na ^a   Ko, Kam Ming ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Antioxidant; Glutathione; Glutathione recovery capacity; Oxidative stress; Schisandrins

Indexed keywords

GLUTATHIONE; N,N' BIS(CHLOROETHYL) N NITROSOUREA; NITROSOUREA DERIVATIVE; SCHIZANDRIN A; SCHIZANDRIN B; SCHIZANDRIN C; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL PROTECTION; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 84155162549     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.179     Document Type: Article

References (25)

1. Bast, A. and Goris, R. J. ( 1989) Oxidative stress. Biochemistry and human disease. Pharm. Weekbl Sci. 11, 199-206.
2. Shan, X. Q., Aw, T. Y., and Jones, D. P. ( 1990) Glutathione-dependent protection against oxidative injury. Pharmacol. Ther. 47, 61-71.
3. Pias, E. K. and Aw, T. Y. ( 2002) Early redox imbalance mediates hydroperoxide-induced apoptosis in mitotic competent undifferentiated PC-12 cells. Cell Death Differ. 9, 1007-1016.
4. Carlberg, I. and Mannervik, B. ( 1985) Glutathione reductase. Methods Enzymol. 113, 484-490.
5. Lu, S. C. ( 2009) Regulation of glutathione synthesis. Mol. Aspects Med. 30, 42-59.
6. Hancke, J. L., Burgos, R. A., and Ahumada, F. ( 1999) Schisandra chinensis (Turcz) Baill. Fitotherapia 70, 451-471.
7. Chiu, P. Y., Leung, H. Y., and Ko, K. M. ( 2008) Schisandrin B enhances renal mitochondrial antioxidant status, functional and structural integrity, and protects against gentamicin-induced nephrotoxicity in rats. Biol. Pharm. Bull. 31, 602-605.
8. Ko, K. M. and Lam, B. Y. ( 2002) Schisandrin B protects against tert-butylhydroperoxide induced cerebral toxicity by enhancing glutathione antioxidant status in mouse brain. Mol. Cell Biochem. 238, 181-186.
9. Chiu, P. Y., Leung, H. Y., Poon, M. K., and Ko, K. M. ( 2006) Chronic schisandrin B treatment improves mitochondrial antioxidant status and tissue heat shock protein production in various tissues of young adult and middle-aged rats. Biogerontology 7, 199-210.
10. Chen, N., Chiu, P. Y., and Ko, K. M. ( 2008) Schisandrin B enhances cerebral mitochondrial antioxidant status and structural integrity, and protects against cerebral ischemia/reperfusion injury in rats. Biol. Pharm. Bull. 31, 1387-1391.
11. Yim, T. K. and Ko, K. M. ( 1999) Schisandrin B protects against myocardial ischemia-reperfusion injury by enhancing myocardial glutathione antioxidant status. Mol. Cell Biochem. 196, 151-156.
12. Yim, T. K. and Ko, K. M. ( 1999) Methylenedioxy group and cyclooctadiene ring as structural determinants of schisandrin in protecting against myocardial ischemia-reperfusion injury in rats. Biochem. Pharmacol. 57, 77-81.
13. Lin, L. Y., Di Stefano, E. W., Schmitz, D. A., Hsu, L., Ellis, S. W., Lennard, M. S., Tucker, G. T., and Cho, A. K. ( 1997) Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6. Drug Metab. Dispos. 25, 1059-1064.
14. Chen, N. and Ko, M. ( 2010) Schisandrin B-induced glutathione antioxidant response and cardioprotection are mediated by reactive oxidant species production in rat hearts. Biol. Pharm. Bull. 33, 825-829.
15. Ko, K. M., Chen, N., Leung, H. Y., Leong, E. P., Poon, M. K., and Chiu, P. Y. ( 2008) Long-term schisandrin B treatment mitigates age-related impairments in mitochondrial antioxidant status and functional ability in various tissues, and improves the survival of aging C57BL/6J mice. Biofactors 34, 331-342.
16. Lam, P. Y., Chiu, P. Y., Leung, H. Y., Chen, N., Leong, P. K., and Ko, K. M. ( 2010) Schisandrin B co-treatment ameliorates the impairment on mitochondrial antioxidant status in various tissues of long-term ethanol treated rats. Fitoterapia 81, 1239-1245.
17. Chiu, P. Y., Leung, H. Y., Poon, M. K., Mak, D. H., and Ko, K. M. ( 2006) (-)Schisandrin B is more potent than its enantiomer in enhancing cellular glutathione and heat shock protein production as well as protecting against oxidant injury in H9c2 cardiomyocytes. Mol. Cell Biochem. 289, 185-191.
18. Chiu, P. Y., Leung, H. Y., Poon, M. K., Mak, D. H., and Ko, K. M. ( 2006) Effects of schisandrin B enantiomers on cellular glutathione and menadione toxicity in AML12 hepatocytes. Pharmacology 77, 63-70.
19. Lam, P. Y. and Ko, K. M. ( 2011) (-)Schisandrin B ameliorates paraquat-induced oxidative stress by suppressing glutathione depletion and enhancing glutathione recovery in differentiated PC12 cells. Biofactors 37, 51-57.
20. Ip, S. P., Poon, M. K., Wu, S. S., Che, C. T., Ng, K. H., Kong, Y. C., and Ko, K. M. ( 1995) Effect of schisandrin B on hepatic glutathione antioxidant system in mice: protection against carbon tetrachloride toxicity. Planta. Med. 61, 398-401.
21. Chiu, P. Y. and Ko, K. M. ( 2004) Schisandrin B protects myocardial ischemia-reperfusion injury partly by inducing Hsp25 and Hsp70 expression in rats. Mol. Cell Biochem. 266, 139-144.
22. Chiu, P. Y., Luk, K. F., Leung, H. Y., Ng, K. M., and Ko, K. M. ( 2008) Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and inhibit associated changes in Ca2+-induced mitochondrial permeability transition and mitochondrial membrane potential in H9c2 cardiomyocytes. Life Sci. 82, 1092-1101.
23. Li, L., Pan, Q., Han, W., Liu, Z., Li, L., and Hu, X. ( 2007) Schisandrin B prevents doxorubicin-induced cardiotoxicity via enhancing glutathione redox cycling. Clin. Cancer Res. 13, 6753-6760.
24. Griffith, O. W. ( 1999) Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic. Biol Med. 27, 922-935.
25. Harvey, C. J., Thimmulappa, R. K., Singh, A., Blake, D. J., Ling, G., Wakabayashi, N., Fujii, J., Myers, A., and Biswal, S. ( 2009) Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic. Biol. Med. 46, 443-453.